Creating a new ultrasound scanner to detect how well breast cancer responds to chemotherapy
Developing a quantitative ultrasound breast scanner for identifying early response of breast cancer to chemotherapy
This study is testing a new type of ultrasound scanner that creates detailed 3D images of breast tumors to help doctors see how well chemotherapy is working for breast cancer patients, aiming to catch changes earlier than traditional methods.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10893424 on NIH RePORTER |
What this research studies
This research focuses on developing advanced imaging techniques using the QT Ultrasound® tomographic breast scanner to better assess how breast cancer patients respond to chemotherapy. By integrating quantitative analysis of ultrasound backscatter with this new scanner, the goal is to provide more accurate and early evaluations of treatment effectiveness. This approach aims to overcome limitations of traditional methods, which often fail to detect patient responses in a timely manner. The research will involve testing the scanner's ability to produce detailed 3D images that can reveal changes in breast tumors during treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients undergoing chemotherapy who require monitoring of their treatment response.
Not a fit: Patients who are not undergoing chemotherapy or those with non-breast cancer conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate identification of breast cancer patients who are responding to chemotherapy, potentially improving treatment outcomes.
How similar studies have performed: Previous research has shown promise in using quantitative ultrasound techniques for assessing treatment responses, indicating that this approach may be effective.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Oelze, Michael L. — University of Illinois at Urbana-Champaign
- Study coordinator: Oelze, Michael L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.